Tuesday, August 30th, 2011
When the Prescription Medicines Code of Practice Authority (PMCPA) reprimanded Bayer HealthCare this month for breaching the ABPI Code of Practice in two of the company’s postings on Twitter, the ruling may have exacerbated wariness about social media within the pharmaceutical industry.
Industry sources say, though, that drug companies should not ...
Posted in
Social media in pharma, adherence and compliance |
2 Comments »
Tuesday, November 17th, 2009
I had a chance to catch up with John Kamp, executive director of the Coalition for Healthcare Communications, to get his post-game analysis of last week’s FDA hearing on the pharmaceutical industry’s use of social media. Overall, Mr. Kamp was pleased with the presentations made by the industry and the ...
Posted in
DTC advertising, Patient education, Professional education, Technology, e-Marketing |
No Comments »
Thursday, November 12th, 2009
It was a tense countdown to the FDA social media hearings, but the first half of the first day proceeded relatively smoothly. The mainstream media did some coverage: here's AP's story, Forbes' Laurie Burkitt said FDA will likely squash the drug industry's social life on the Web, and Scott Hensley ...
Posted in
Uncategorized |
5 Comments »
Thursday, November 5th, 2009
It's one week until the FDA hearings on pharmaceutical promotion and social media, and the chatter on the Tweet stream has turned into a frenzied roar. During the hearings themselves, the Tweet stream may actually be quieter, since it's been reported that the hearing room itself is in a building ...
Posted in
Economy, Uncategorized |
3 Comments »
Tuesday, May 19th, 2009
Due to real estate constraints, we can't always include every interesting article that we want in the paper issue of Med Ad News. The article below didn't quite make the cut for May's Sales & Marketing department. But I thought it was interesting, both for the rebuke of FDA and ...
Posted in
Sales & Marketing |
No Comments »
Wednesday, May 13th, 2009
This was a not-so-pleasant surprise to find first thing Tuesday morning: an EU court ruled that media comment on medicines may constitute advertising. The case involves Danish journalist Frede Damgaard, who wrote back in 2003 on his Website about a natural supplement called Hyben Total, which was initially licensed for ...
Posted in
Legal actions, Uncategorized |
No Comments »
Tuesday, April 7th, 2009
FDA has cracked down on sponsored links that show up on Google and other search engines on behalf of 14 different pharmaceutical companies: Bayer AG, Biogen Idec Inc., Boehringer Ingelheim Pharmaceuticals Inc., Cephalon Inc., Forest Laboratories Inc., Genentech Inc., GlaxoSmithKline, Johnson & Johnson, Eli Lilly and Co., Merck & Co., ...
Posted in
DTC advertising, Legal actions, Patient education, Sales & Marketing |
2 Comments »
Tuesday, January 20th, 2009
Earlier this month, FDA issued a final guidance on Good Reprint Practices, which will make it easier for pharmaceutical companies to advise doctors on unapproved uses of medicines. The guidance sets out FDA's new thinking when it comes to the distribution of medical journal articles and scientific or medical reference ...
Posted in
FDA Files, Med Ad News |
1 Comment »
|
|
